EBS

Emergent Biosolutions INC

-$183.3M

Net Activity

Institutions Holding

191

Popularity Rank

#3011

Avg Weight

0.03%

Total Value

$357.9M

Ownership Trend

191 institutions currently hold EBS, with 101 net buyers and 79 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

79

Net Buying Institutions

101

Key Holders

View all 191 holding institutions

Quarterly Activity

Recent Activity

+$208.2M

Total Buy Value

$239.0M

Total Sell Value

New buy31
Trim55
Add70
Sold out24

101

Net Buyers

79

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

1

Filings (90d)

$25K

Total Est. Value

3K shares

Planned Shares

Last Filed 2026-07-01
FilerFiling DateEst. Value
PAUL WILLIAMS2026-07-01$25K

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding EMERGENT BIOSOLUTIONS INC (EBS)?
Major stakeholders currently include BlackRock, Inc. ($36.0M), State Street CORP ($23.7M), Dimensional Fund Advisors LP ($22.9M). Based on the latest 13F filings, there are a total of 191 tracked investment funds and institutions maintaining positions in EBS.
What is the overall institutional sentiment toward EBS recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $183.3M, driven by 101 managers accumulating shares while 79 reduced their exposure.
Which institutions have been selling or reducing their EBS positions?
In the latest period, 55 funds trimmed their holdings, and 24 managers completely exited their positions. The aggregate reported sell value was $239.0M.
Are there any notable investors adding EBS to their portfolios?
Yes, buying activity remains notable. 31 institutions opened new positions in {ticker}, and 70 existing holders added to their shares. The total reported buy value for the quarter amounted to $208.2M.

Related Stocks